Advertisement

Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option

Authors

  • Angelo Sangiovanni M.D.,

    1. A.M. & A. Migliavacca Center for Liver Disease
    2. Department of Medicine, 1st Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Università di Milano, Milan, Italy
    Search for more papers by this author
  • Massimo Colombo M.D.

    Corresponding author
    1. A.M. & A. Migliavacca Center for Liver Disease
    2. Department of Medicine, 1st Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Università di Milano, Milan, Italy
    • 1st Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Via F. Sforza 35, 20122 Milan, Italy
    Search for more papers by this author
    • fax: 39-0250320410


  • Potential conflict of interest: Dr. Colombo advises, is on the speakers' bureau of, and received grants from Merck, Bayer, Roche, Bristol-Myers Squibb, and Gilead.

  • See Article on Page 1956

No abstract is available for this article.

Ancillary